Cargando…

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids

BACKGROUND: Schizophrenia is thought to be a neurodevelopmental disorder with pathophysiological processes beginning in the brain prior to the emergence of clinical symptoms. Recent evidence from neuroimaging studies using techniques such as diffusion tensor imaging has identified white matter abnor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vijayakumar, Nandita, Bartholomeusz, Cali, Whitford, Thomas, Hermens, Daniel F., Nelson, Barnaby, Rice, Simon, Whittle, Sarah, Pantelis, Christos, McGorry, Patrick, Schäfer, Miriam R., Amminger, G. Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982267/ https://www.ncbi.nlm.nih.gov/pubmed/27515430 http://dx.doi.org/10.1186/s12888-016-0932-4

Ejemplares similares

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research
por: Nelson, Barnaby, et al.
Publicado: (2018)

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis
por: Mechelli, Andrea, et al.
Publicado: (2017)

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2018)

Persistent negative symptoms in individuals at Ultra High Risk for psychosis
por: Yung, Alison R., et al.
Publicado: (2019)

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
por: Amminger, G P, et al.
Publicado: (2015)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

M22. IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2020)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis
por: Bousman, C A, et al.
Publicado: (2013)

Erythrocyte glutathione levels as long-term predictor of transition to psychosis
por: Lavoie, S, et al.
Publicado: (2017)

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers
por: Clark, S R, et al.
Publicado: (2016)

Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
por: Cheng, Nicholas, et al.
Publicado: (2022)

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis
por: Berger, Gregor E., et al.
Publicado: (2016)

M21. THE STEP TRIAL: A SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMISED TRIAL (SMART) OF INTERVENTIONS FOR PATIENTS AT ULTRA-HIGH RISK OF PSYCHOSIS - STUDY RATIONALE, DESIGN AND BASELINE DATA
por: Nelson, Barnaby, et al.
Publicado: (2020)

4.3 ENHANCING SOCIAL FUNCTIONING AND LONG-TERM RECOVERY IN YOUNG PEOPLE WITH FIRST EPISODE PSYCHOSIS (FEP) AND YOUNG PEOPLE AT ULTRA HIGH RISK (UHR) FOR PSYCHOSIS: A NOVEL ONLINE SOCIAL THERAPY APPROACH
por: Alvarez-Jimenez, Mario, et al.
Publicado: (2018)

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study
por: Berger, M E, et al.
Publicado: (2017)

T30. TIPPING POINTS – PREDICTING TRANSITIONS TO PSYCHOSIS IN AT-RISK YOUNG PEOPLE
por: Hartmann, Jessica A, et al.
Publicado: (2018)

Delayed sleep onset in depressed young people
por: Glozier, Nicholas, et al.
Publicado: (2014)

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis
por: Schirmbeck, Frederike, et al.
Publicado: (2021)

Early Intervention in Psychosis: Obvious, Effective, Overdue
por: McGorry, Patrick D.
Publicado: (2015)

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia
por: Di Biase, M A, et al.
Publicado: (2017)

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL
por: Allott, Kelly, et al.
Publicado: (2018)

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
por: Föcking, Melanie, et al.
Publicado: (2016)

Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis
por: Tognin, S., et al.
Publicado: (2014)

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS
por: Cropley, Vanessa, et al.
Publicado: (2018)

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
por: Berger, Maximus, et al.
Publicado: (2019)

PM485. Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis
por: Jhon, Min, et al.
Publicado: (2016)

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
por: Cotton, S. M., et al.
Publicado: (2019)

Discharge destinations for young people with a first episode of psychosis after attending an early intervention for psychosis service
por: O’Donoghue, Brian, et al.
Publicado: (2023)

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
por: Berger, Maximus, et al.
Publicado: (2020)

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
por: Amminger, G. Paul, et al.
Publicado: (2015)

The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research
por: Brown, Ellie, et al.
Publicado: (2020)

T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL
por: Schlögelhofer, Monika, et al.
Publicado: (2020)

Cognitive ability and metabolic physical health in first-episode psychosis
por: Whitson, Sarah, et al.
Publicado: (2021)

Neurocognitive and Social Cognitive Approaches for Improving Functional Outcome in Early Psychosis: Theoretical Considerations and Current State of Evidence
por: Bartholomeusz, Cali F., et al.
Publicado: (2012)

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS
por: Hartmann, Jessica A, et al.
Publicado: (2018)

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course
por: Nelson, B., et al.
Publicado: (2018)

S166. EFFECTIVE CONNECTIVITY OF FRONTOSTRIATAL SYSTEMS IN FIRST-EPISODE PSYCHOSIS
por: Sabaroedin, Kristina, et al.
Publicado: (2020)

Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective
por: Ong, Hui Lin, et al.
Publicado: (2021)

Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypy
por: Oldehinkel, Marianne, et al.
Publicado: (2023)

The need for early intervention for psychosis to persist throughout the COVID-19 pandemic and beyond
por: O’Donoghue, B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3mpa4cigru1p0foicn2b0d2jn